Filter
1076
Filtered Results: 1076
Text search:
rifampicina
Featured
Recommendations
124
New Publications
292
Language
Document type
No document type
717
Guidelines
151
Studies & Reports
84
Manuals
50
Strategic & Response Plan
27
Training Material
19
Fact sheets
17
Situation Updates
6
Infographics
3
App
1
Resource Platforms
1
Countries / Regions
Western and Central Europe
58
India
58
Eastern Europe
32
South Africa
25
Nepal
23
Latin America and the Carribbean
22
Kenya
20
Tanzania
18
Colombia
16
Argentina
16
Peru
15
Nigeria
14
Germany
14
Bangladesh
14
Namibia
14
Paraguay
13
Uganda
13
Indonesia
13
Brazil
12
Ethiopia
12
Zambia
12
El Salvador
11
Rwanda
11
Global
11
Bolivia
10
Philippines
9
Cambodia
9
South–East Asia Region
9
Myanmar / Burma
9
Ukraine
8
Malawi
8
Senegal
7
Mozambique
7
Africa
7
Asia
7
Cameroon
6
Congo, Democratic Republic of
6
Russia
6
Tajikistan
5
Uruguay
5
Ecuador
5
Eswatini/ Swaziland
5
Ghana
4
Benin
4
Chile
4
Venezuela
4
Botswana
4
Lesotho
3
Sierra Leone
3
Burkina Faso
3
Zimbabwe
3
Georgia
3
Bhutan
3
Madagascar
3
Pakistan
3
Timor Leste/ East Timor
2
Syria
2
Armenia
2
Haiti
2
Eastern Europe and Central Asia
2
Sri Lanka
2
Liberia
2
North Macedonia
1
North Korea
1
Switzerland
1
Thailand
1
Mexico
1
Serbia
1
Gambia
1
Togo
1
Kazakhstan
1
Iran
1
Albania
1
Fiji
1
Laos
1
Kyrgyzstan
1
Uzbekistan
1
Afghanistan
1
Malaysia
1
Morocco
1
Dominican Republic
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
North America
1
Turkmenistan
1
Tunisia
1
Spain
1
Lebanon
1
Vietnam
1
Nicaragua
1
Sudan
1
Yemen
1
Romania
1
Greece
1
Honduras
1
Libya
1
Iraq
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
258
TB
85
Guidelines
67
Studies & Reports
50
Drugs & Medical Equipment
43
Capacity Building
29
Policies
26
HIV & STI
21
Women & Child Health
20
Pediatrics
18
Statistics
18
Disease Prevention & Control
12
Community Health
10
Paediatrics
9
Bacteriology
9
Buruli Ulcer
8
COVID-19
8
Leprosy
8
Leprosy
7
Reproductive Health
7
Family Planning
6
Dermatology
6
Maternal & Child Health
5
Countries
5
Clinical Guidelines
5
Demograhic Health Surveys DHS
5
Communicable Diseases
5
NTDs & Others
5
Community Health
4
Vaccine-preventable Diseases
4
Communicable Diseases
3
Infection Control & Prevention (IPC)
3
Public Health
3
Clinical Training
2
Hepatitis
2
Under-5 nutrition
2
Diabetes
2
Trachoma
2
Lymphaticfilariasis
2
Monitoring & Evaluation
2
Virology
2
Medical Devices & Equipment
2
Other
2
General Guidelines
2
Health Systems
2
Leishmaniasis
2
Dental & Eye Care
1
Public Health
1
Pharmacy & Technology
1
Child Health
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
x MEDBOX Issue Brief & Annual Reports x
1
General Guidelines
1
IEC Material
1
Health System Strengthening
1
Information, Education and Communication (IEC)
1
Disabilities
1
Humanitarian Crisis
1
Respiratory Infections
1
Primary Health Care
1
Malaria
1
Pharmacy & Technologies
1
Toolboxes
Prevention & Control
52
Drug resistant TB
51
Detection & Diagnosis
50
Adults
43
Children
27
Training
25
TB/HIV Coinfection
24
Essential Medicines & Devices Lists
21
Childhood TB
17
TB & Prisoners
17
Antiretroviral Treatment ART
16
Reports
15
Research & Access
15
General
14
TB
14
Policies & Strategies
13
Treatment & Prevention
13
Children & Adolescents
13
Laboratory
13
Disease Prevention & Control
13
Clinical Aspects, Treatment & Prevention
12
Clinical Aspects
12
Colombia
12
Peru
12
AmR (Region of Americas)
12
Brazil
11
Other Countries
11
Clinical Aspects & Diagnostics
11
Romania
11
Germany
11
Eastern Europe & Central Asia
11
SEAR (South-east Asia Region)
10
Moldova
9
Policies & Strategies
9
El Salvador
9
Argentina
9
Studies & Reports
9
Reports & Studies
9
Country specific
8
Treatment Guidelines HIV
8
Prevention & Control
8
TB & Other Vulnerable Populations
8
TB/HIV
8
Biosafety
7
Country Guidelines
7
International
7
Communication & Training
7
Advocacy & Communication
7
HIV &TB
7
Policies and guidelines
7
HIV and coinfection
7
Treatment & Clinical Management
7
South Africa
6
Namibia
6
Drug resistance
6
Studies
6
Overview
6
Essential Medicines
6
General
6
TB/HIV Global
6
Uganda
6
South-east Asia Region
6
Epidemiology
6
Kenya
6
ART Drug Resistance
5
TB & Drug Abuse
5
Ukraine
5
Rwanda
5
TB/COVID-19
5
Diagnosis
5
Malawi
5
Assessment
5
Clinical Guidelines
5
Opportunistic Infections
4
Training Manuals
4
Ethiopia
4
Clinical Guidelines
4
Community Health Workers CHW
4
Chile
4
Ecuador
4
Falsified & Substandard
4
Tuberculosis
4
Nutrition
4
Latin America & the Carribean
4
Tajikistan
4
Kazakhstan
4
Western & Central Europe
4
Eastern Europe and central Asia
4
General Reports
3
Azerbaijan
3
Vaccines & Immunization
3
Epidemiology & Sitreps
3
Eastern Mediterranean Region
3
National Policies
3
IEC Materials
3
Mozambique
3
Georgia
3
Clinical aspects
3
Workplace
3
Clinical Guidelines
3
Country specific documents
3
Hospital Readiness/Essential Health Services
3
Latin America
3
Pharmacy Practice
3
Rational use of Medicine
3
Access to treatment and laboratory
3
Co-Morbidities (except TB)
3
Prophylactic Treatment
3
Nigeria
3
Drugs
2
Behaviour Change/Life Skill Education
2
Meningitis Prevention & Control
2
Clinical Guidelines
2
Pediatrics
2
WPRO (Western Pacific Region)
2
HIV
2
Prophylaxis
2
SOPs
2
Health & Refugee
2
Epilepsy
2
Sustainable Development Goals
2
General
2
Essential List
2
Country Specific
2
Global Impact: Socio-economic, health services, TB & HIV
2
Others
2
Latin America
2
Prices and Patents
2
Model Formulary
2
Prevention & Measures
2
Disability Prevention & Rehabilitation
2
Information & Education Material (IEC)
2
NTDs General
2
Capacity Building & Resource platforms
2
Health Worker
2
Neurological Disorders
2
Ghana
2
HIV service delivery
2
Meningitis & Encephalitis
2
Clinical Guidelines
1
Surveillance
1
Agriculture & Veterinary
1
HIV testing & services
1
Clinical Guidelines
1
Zambia
1
Prevention Guidelines
1
Policies
1
Public Health
1
Eastern Europe
1
TB
1
Global
1
People who injecting Drugs
1
Vaccination
1
African Region
1
Laboratory
1
Belarus
1
HIV / AIDS
1
Medical professionals
1
Russia
1
DR Congo
1
Laboratory
1
Research & Development
1
Estonia
1
Pharmaceutical Assessments
1
General documents One Health
1
Guidelines & Manuals
1
General
1
Health Care In Conflict Settings
1
Leishmaniasis
1
Strategies & Roadmaps
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Clinical Aspects & Diagnostics
1
Vector control
1
Armenia
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Asia and Pacific
1
Botswana
1
General
1
Substance Use Disorders & Addiction
1
Community Worker
1
General Aspects
1
AR (African Region)
1
Education of students & professionals
1
Lesotho
1
HIV / AIDS
1
Testing Guidelines
1
Stigma
1
Overview & Statistics
1
MHPSS Guidelines
1
Guidelines CBR
1
Lobby and Advocacy
1
HIV in Key Populations
1
Preparedness & Prevention
1
Global Health Financing
1
Unaccompanied Refugee Minors
1
Case Definitions
1
Prisoners
1
Key Resources
1
AMR
1
The overall objective of this implementation plan is to define the strategy for implementation of the Xpert MTB/RIF test for rapid detection of TB and rifampicin (RIF) resistance in Tanzania, within the context of the National Tuberculosis and Leprosy Programme (NTLP) strategic plan and other nation...
Consenso de los Laboratorios Supranacionales (LSN), Centros Colaboradores (CC) y Laboratorios Nacionales de Referencia (LNR) de “países priorizados” para la aplicación del Xpert-MTB/Rif en Las Américas.
Guatemala, 11-12 abril de 2011
Accessed December 2017
Accessed March 19,2015
Technical and operational ‘how-to’: practical considerations
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
Глобальными приоритетами для лечения туберкулеза (ТБ) и борьбы с ним являются улучшенное и ранее выявление случаев туберкулеза, в том числе случаев заболевания с о...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv...
Buruli ulcer is caused by infection with Mycobacterium ulcerans. The disease is reported in more than 33 countries worldwide, but only about half of these countries regularly report data to WHO; most cases are reported from subregions of West and Central Africa. The mode of transmission is not known...
L’ulcère de Buruli, une infection causée par Mycobacterium ulcerans, touche plus de 33 pays dans le monde, mais un peu moins de la moitié seulement de ces pays communiquent régulièrement des données sur la maladie à l’OMS. La plupart des cas notifiés se trouvent dans les sous-régions d...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim...
Of the more than 10 million people estimated to have fallen ill with tuberculosis (TB) in 2022, just over 400 000 people developed TB resistant to rifampicin (RIF), and 1.3 million people developed TB resistant isoniazid (INH). Drug resistance must be detected rapidly and accurately to initiate appr...
